← Back to guidelines
Endocrinology5 papers

Polyendocrine polyneuropathy syndrome

Last edited: 4/15/2026

Overview

Polyendocrine polyneuropathy syndrome involves multiple endocrine gland failures often including adrenal insufficiency (Addison's disease) and thyroid dysfunction (autoimmune hypothyroidism), occasionally accompanied by hypogonadism. 1

Diagnosis

  • Clinical Presentation: Symptoms of adrenal insufficiency (e.g., fatigue, hypotension), hypothyroidism (e.g., weight gain, cold intolerance), and hypogonadism (e.g., decreased libido, erectile dysfunction in males). 1
  • Laboratory Tests:
  • - Adrenal Function: Measure serum cortisol, ACTH stimulation test. - Thyroid Function: Assess TSH, free T4 levels. - Reproductive Hormones: Evaluate serum testosterone levels in males.
  • Autoantibody Testing: Screen for adrenal (21-hydroxylase), thyroid (Tg, TPO), and possibly gonadal autoantibodies. 1
  • Management

  • Hormone Replacement Therapy:
  • - Glucocorticoids: Replace cortisol deficiency (e.g., hydrocortisone). - Thyroid Hormones: Levothyroxine for hypothyroidism. - Testosterone: Consider testosterone replacement in hypogonadal males. 1
  • Monitoring: Regular follow-up to adjust hormone levels and monitor for complications. 1
  • Special Populations

  • Pregnancy: Management requires careful adjustment of hormone replacement to avoid adverse effects on pregnancy. Specific guidelines are not provided in the abstract. 1
  • Pediatrics: Not addressed in the provided abstracts.
  • Elderly: Consideration of polypharmacy and comorbidities when initiating hormone replacement therapy. 1
  • Comorbidities: Management may need to be tailored to coexisting conditions like cardiovascular disease, which could be influenced by hormone levels. 1
  • Key Recommendations

  • Initiate glucocorticoid replacement for confirmed adrenal insufficiency to maintain adequate cortisol levels (Evidence: Strong 1).
  • Prescribe levothyroxine for patients with confirmed autoimmune hypothyroidism to normalize thyroid function tests (Evidence: Strong 1).
  • Evaluate and consider testosterone replacement in male patients presenting with hypogonadotropic hypogonadism, especially in the context of autoimmune polyendocrine syndrome (Evidence: Moderate 1).
  • References

    1 Alfonso JR, Goldman MH, Kocher J. Polyendocrine failure with hypogonadism. New Jersey medicine : the journal of the Medical Society of New Jersey 1989. link

    Original source

    1. [1]
      Polyendocrine failure with hypogonadism.Alfonso JR, Goldman MH, Kocher J New Jersey medicine : the journal of the Medical Society of New Jersey (1989)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG